Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Cash & Current Investments: 2010-2017

Historic Cash & Current Investments for Tenax Therapeutics (TENX) over the last 4 years, with Sep 2017 value amounting to $8.5 million.

  • Tenax Therapeutics' Cash & Current Investments rose 14.13% to $8.5 million in Q3 2017 from the same period last year, while for Sep 2017 it was $43.1 million, marking a year-over-year increase of 5.51%. This contributed to the annual value of $13.3 million for FY2016, which is N/A change from last year.
  • Latest data reveals that Tenax Therapeutics reported Cash & Current Investments of $8.5 million as of Q3 2017, which was down 2.98% from $8.8 million recorded in Q2 2017.
  • In the past 5 years, Tenax Therapeutics' Cash & Current Investments ranged from a high of $58.3 million in Q2 2014 and a low of $783,528 during Q2 2013.
  • For the 3-year period, Tenax Therapeutics' Cash & Current Investments averaged around $10.2 million, with its median value being $8.8 million (2017).
  • Its Cash & Current Investments has fluctuated over the past 5 years, first spiked by 7,343.33% in 2014, then tumbled by 86.41% in 2015.
  • Tenax Therapeutics' Cash & Current Investments (Quarterly) stood at $783,528 in 2013, then surged by 7,343.33% to $58.3 million in 2014, then plummeted by 86.41% to $20.2 million in 2015, then slumped by 34.22% to $13.3 million in 2016, then grew by 14.13% to $8.5 million in 2017.
  • Its Cash & Current Investments was $8.5 million in Q3 2017, compared to $8.8 million in Q2 2017 and $12.5 million in Q1 2017.